Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Fluid Measurements and MRI in Determining Biomarkers of Lymphatic Dysfunction in Patients with Breast Cancer

Breast

This trial uses fluid measurements of the arm and MRI to determine biomarkers of lymphatic dysfunction in patients with breast cancer. Studying the lymphatic system (the part of your body that helps to process and clear waste products) in different ways will help doctors understand more about lymphedema (excess fluid after lymph nodes are removed) and help with prevention and management of lymphedema in patients with breast cancer.

Disease Sites: Breast

Phase: N/A

Investigator: Donahue, Manus

NCTID: NCT03760744

Protocol No: VICCBRE18156

Improving Care after Inherited Cancer Testing (IMPACT) Study

Miscellaneous

This clinical trial investigates factors associated with access to genetic risk assessment, counseling, and testings services. The trial also seeks to refine and evaluate the effectiveness of online tools on improving cancer risk management practices and family communication of genetic test results.

Disease Sites: Miscellaneous

Phase: N/A

Investigator: Pal, Tuya

NCTID: NCT04763915

Protocol No: VICCSUPP2112

Expanded Access Study for the Treatment of Patients with Commercially Out-of-Specification Brexucabtagene Autoleucel

Disease Sites: Not Available

Phase: N/A

Investigator: Jallouk, Andrew

NCTID: NCT05776134

Protocol No: VICC-XDCTT23451

Promoting Self-Management in Head and Neck Cancer Survivors with Lymphedema and Fibrosis [PROMISE Trial]

Disease Sites: Not Available

Phase: N/A

Investigator: Murphy, Barbara

NCTID: NCT06125743

Protocol No: VICC-EDHAN23569

Expanded Access Study for the Treatment of Patients with Commercially Out-of-Specification Axicabtagene Ciloleucel

Disease Sites: Not Available

Phase: N/A

Investigator: Jallouk, Andrew

NCTID: NCT05776160

Protocol No: VICC-XDCTT23452

AssesSing a Biomarker PlatfOrm for STratifying IndeterminaTe Pulmonary Nodules; The SPOT IT Platform Trial

Disease Sites: Not Available

Phase: N/A

Investigator: Maldonado, Fabien

NCTID: NCT06638398

Protocol No: VICC-IDTHO24059

The CRYSTAL Study: CRYoablation Study for Outpatient Treatment of EArly-Stage Lung Cancer

Disease Sites: Not Available

Phase: N/A

Investigator: Maldonado, Fabien

NCTID: NCT06593106

Protocol No: VICC-VCTHO24099

An Open Label, Expanded Access Protocol using 131I-Metaiodobenzylguanidine (131I-MIBG) Therapy in Patients with Refractory Neuroblastoma, Pheochromocytoma, or Paraganglioma

Multiple Cancer Types

Disease Sites: Neuroblastoma (Pediatrics), Pediatric Solid Tumors

Phase: N/A

Investigator: Kitko, Carrie

NCTID: NCT01590680

Protocol No: VICCPED1249

Intermediate-Size Population Expanded Access Program (EAP) for Ciltacabtagene Autoleucel (Cilta-Cel) Out-of-Specification (OOS) in Patients with Multiple Myeloma

Multiple Myeloma

Disease Sites: Multiple Myeloma

Phase: N/A

Investigator: Oluwole, Olalekan

NCTID: NCT05346835

Protocol No: VICC-XDCTT24033

Clinical Trial Flowcharts
for Referring Physicians

Clinical Trial Flowcharts
for VICC Staff (VUNetID required)

Clinical Trials Search CTA Inline Referral Form